The Dutch government has suspended its intervention in chipmaker Nexperia in a bid to ease tension with Beijing and prevent a potential global shutdown of car plants, reports the Financial Times. In a statement on Wednesday, Dutch economic affairs minister Vincent Karremans said the government was taking the step following “constructive” discussions with the Chinese […]
Category:
China International Capital Corp. Ltd. (CICC) plans to acquire two smaller sibling brokerages, Dongxing Securities Co. Ltd. and Cinda Securities Co. Ltd., in a major shake-up of China’s fragmented brokerage industry, reports Caixin. In separate statements issued Wednesday evening, the three companies said CICC would absorb Dongxing and Cinda through a share-swap transaction. Trading in […]
China imported no soybeans from the US for a second straight month in October even as total imports surged to a record high on purchases from South America, with buyers aiming to avert supply disruptions amid trade tensions with Washington, reports Reuters. Data from China’s General Administration of Customs on Thursday showed US soybean imports […]
Categories
Kuaishou profit soars 70%
Kuaishou Technology Co. Ltd. posted a 70% surge in third-quarter operating profit, as its ramped-up investment in artificial intelligence began bearing fruit—especially in its core advertising segment, reports Caixin. The Beijing-based short-video company reported operating profit of RMB 5.3 billion ($746 million) for the three months ended in September, according to earnings released Wednesday. Revenue […]
Categories
China clinical trial capacity matches US
China’s growing pipeline of novel drug candidates is expected to draw increased attention from global pharmaceutical companies and investors scouting for licensing opportunities, as the country’s clinical trial capacity has expanded to match those in the US, reports the South China Morning Post. As of 2024, China’s clinical trial volumes matched 80% of those in the […]